<?xml version="1.0" encoding="utf-8"?>
<item href="/news/in-the-media/2024/articles/1711993258.php" dsn="blogs">
  <type>external</type>
  <image>
    <img src="https://newhaven.edu/_resources/images/faculty-staff-headshots/angeli-gianchandani.jpg" alt="Angeli Gianchandani"/>
  </image>
  <category>In the Media</category>
  <image-caption/>
  <title>Healthnews: We Live in the Economy of Ozempic</title>
  <pubDate>March 29, 2024</pubDate>
  <description>Angeli Gianchandani, a practitioner in residence of marketing and the MBA program, comments on the economic impact on the food and restaurant industry as more customers are taking GLP-1 receptor agonists, adding that the industry may need to change their food offerings to accommodate this group.</description>
  <hide-description/>
  <external_link>https://healthnews.com/news/we-live-in-the-economy-of-ozempic/#:~:text=We%20Live%20in%20the%20Economy%20of%20Ozempic&amp;amp;text=Ozempic%20and%20other%20GLP%2D1,to%20a%20Trilliant%20Health%20analysis</external_link>
  <hide-description/>
  <author>angeli-gianchandani</author>
  <author-details/>
  <hide-author/>
  <image-caption/>
  <hide-image/>
  <tags>
    <tag>news-all</tag>
    <tag>news-in-the-media</tag>
    <tag>year-2024</tag>
    <tag>month-march</tag>
    <tag>name-angeli-gianchandani</tag>
  </tags>
</item>
